戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1               A. baumannii had high level of resistance to antibiotics.
2 m biofilms, it can evade and rapidly develop resistance to antibiotics.
3              Efflux is a common mechanism of resistance to antibiotics.
4 r interactions mediated by production of and resistance to antibiotics.
5 ring RNA stability, and conferring bacterial resistance to antibiotics.
6 la enterica that are all validated to confer resistance to antibiotics.
7 solve the challenges arising from increasing resistance to antibiotics.
8  pumps significantly contribute for bacteria resistance to antibiotics.
9 f enzymes that plays a key role in bacterial resistance to antibiotics.
10  prevalent pathogen that can rapidly acquire resistance to antibiotics.
11  garnering notoriety in an era of increasing resistance to antibiotics.
12 problematic outbreaks and acquire high-level resistance to antibiotics.
13 racellular residency, biofilm formation, and resistance to antibiotics.
14 ences in phenotypes, including virulence and resistance to antibiotics.
15 ble by vaccination and is rapidly developing resistance to antibiotics.
16 ficult to eradicate because of its intrinsic resistance to antibiotics.
17  vivo fitness, cell envelope homeostasis and resistance to antibiotics.
18 ion, and potential contribution to bacterial resistance to antibiotics.
19 d with mutations, can contribute to adaptive resistance to antibiotics.
20  it has led to a rapid increase in bacterial resistance to antibiotics.
21 "intrinsic resistome," which provides innate resistance to antibiotics.
22 Gram-negative bacteria and provide intrinsic resistance to antibiotics.
23  a major health threat because of increasing resistance to antibiotics.
24 elements responsible for spreading bacterial resistance to antibiotics.
25 nificant mechanism by which bacteria develop resistance to antibiotics.
26 fication as well as their ability to develop resistance to antibiotics.
27 ons continues to be complicated by expanding resistance to antibiotics.
28 pid spread of genes such as those conferring resistance to antibiotics.
29 gly difficult to treat due to high levels of resistance to antibiotics.
30 notypic delay for the evolution of bacterial resistance to antibiotics.
31 ructural basis of catalysis and mechanism of resistance to antibiotics.
32 ulated genes points to mechanisms of biofilm resistance to antibiotics.
33 hages in the age of widespread antimicrobial resistance to antibiotics.
34         There is evidence of rapidly growing resistance to antibiotics across Africa.
35 ic outcomes and containing further spread of resistance to antibiotics among other bacteria.
36 tems are necessary for metabolic regulation, resistance to antibiotics and antimicrobials, pathogenes
37 inhibitors and often contribute to multidrug resistance to antibiotics and biocides.
38      Efflux pumps have been shown to mediate resistance to antibiotics and cationic peptides in other
39 ellular superstructure can display increased resistance to antibiotics and cause serious, persistent
40 omplex multicellular assemblies that exhibit resistance to antibiotics and contribute to the pathogen
41 ts prominence as a pathogen is its intrinsic resistance to antibiotics and disinfectants.
42                  Its predilection to develop resistance to antibiotics and expression of multiple vir
43     Results showed the safety of probiotics, resistance to antibiotics and gastric acid, and potentia
44 states during 1978-2019 to examine bacterial resistance to antibiotics and heavy metals.
45 ich includes imparting significantly greater resistance to antibiotics and host immune effectors.
46           In developing countries, increased resistance to antibiotics and its cost make eradication
47 ty testing platform to recognize patterns of resistance to antibiotics and make predictions about the
48 the same genetic determinant responsible for resistance to antibiotics and metals).
49  Bacillus subtilis are broadly implicated in resistance to antibiotics and other cell envelope stress
50 e selecting drugs, chromosomal mutations for resistance to antibiotics and other chemotheraputic agen
51 sion of multiple chromosomal genes affecting resistance to antibiotics and other environmental hazard
52 ial MDRs had previously been associated with resistance to antibiotics and other toxic compounds.
53                        With a high intrinsic resistance to antibiotics and the ability to overcome ch
54  to play an important role in the bacteria's resistance to antibiotics and the host immune response.
55                   The emerging and sustained resistance to antibiotics and the poor pipeline of new a
56        The emergence of superbugs developing resistance to antibiotics and the resurgence of microbia
57 ted functions of these genes are: conferring resistance to antibiotics and toxic compounds, and enabl
58  an isolate, testing its properties, such as resistance to antibiotics and virulence, and monitoring
59 ucture reveals the molecular basis for broad resistance to antibiotics and will inform the design of
60 ), and sigma(X)) are induced by, and provide resistance to, antibiotics and other agents eliciting ce
61 ere pneumonia in young children), increasing resistance to antibiotics, and changes in HIV prevalence
62 ay the dominant role in conferring intrinsic resistance to antibiotics, and provide initial insights
63 fferent biofilms compositions, increased the resistance to antibiotics, and some changed the cell wal
64 outcomes of increased infectivity, intrinsic resistance to antibiotics, and subversion of the host im
65 bidity and mortality and, because of biofilm resistance to antibiotics, are difficult to treat.
66  only display distinct phenotypes, including resistance to antibiotics, but also, serve as building b
67 entical bacteria display differing levels of resistance to antibiotics, clonal yeast populations demo
68 he typical ARG profiles suggest a prevailing resistance to antibiotics commonly used in human health
69                                   Increasing resistance to antibiotics creates the need for prudent a
70                        The rise in bacterial resistance to antibiotics demonstrates the medical need
71    However, the development of antimicrobial resistance to antibiotics, demonstrates a need to find a
72  populations exhibit non-genetic or adaptive resistance to antibiotics, despite sustaining considerab
73  eradicate because of their unusually robust resistance to antibiotics, disinfectants, and desiccatio
74                                              Resistance to antibiotics has become a major threat to m
75        The emergence and spread of bacterial resistance to antibiotics has developed into one of the
76 own genetic components underlying phenotypic resistance to antibiotics has increased.
77                   The continued evolution of resistance to antibiotics has led to wide ranging consul
78                                    Bacterial resistance to antibiotics has reached critical levels, s
79 genetic material in bacteria that encode for resistance to antibiotics) have been found in the aquati
80 ly related to these shifts include those for resistance to antibiotics, heavy metals, and phage.
81                         Mutations that cause resistance to antibiotics in bacteria often reduce growt
82                                    Bacterial resistance to antibiotics in this clinical setting furth
83 a challenge for treatment due to its evolved resistance to antibiotics, including carbapenems.
84 icult to treat due to intrinsic and acquired resistance to antibiotics, including vancomycin.
85                   The emergence of bacterial resistance to antibiotics is a major health problem and,
86                             The emergence of resistance to antibiotics is a serious problem often rel
87 ncing for phenotype prediction as the actual resistance to antibiotics is almost exclusively mediated
88                                              Resistance to antibiotics is approaching crisis levels f
89             Increased Gram-negative bacteria resistance to antibiotics is becoming a global problem,
90                             The incidence of resistance to antibiotics is increasing; therefore, it i
91 jejuni is a major zoonotic pathogen, and its resistance to antibiotics is of great concern for public
92  of P. aeruginosa and its ability to develop resistance to antibiotics, it continues to be problemati
93         With the rapid increase of infection resistance to antibiotics, it is urgent to find novel in
94 he survival of bacteria and the evolution of resistance to antibiotics make it an attractive target f
95                                    Bacterial resistance to antibiotics makes previously manageable in
96 animal-adapted S. aureus lineages exhibiting resistance to antibiotics must be considered a major thr
97             Conversely, mutations conferring resistance to antibiotics not administered diminish and
98 deration, such as public good production and resistance to antibiotics or predation, are often assume
99   Gram-negative bacteria develop and exhibit resistance to antibiotics, owing to their highly asymmet
100                                    Bacterial resistance to antibiotics, particularly plasmid-encoded
101                                    Bacterial resistance to antibiotics, particularly to multiple drug
102                 We postulate that phenotypic resistance to antibiotics, persistence, is not an evolve
103                                              Resistance to antibiotics poses a major global threat ac
104                      The spread of bacterial resistance to antibiotics poses the need for antimicrobi
105            With increase in the incidence of resistance to antibiotics, probiotics are emerging as a
106 sion as measured by mtrCDE transcription and resistance to antibiotics, progesterone and antimicrobia
107                It has long been assumed that resistance to antibiotics reduces the fitness of disease
108            The increasing threat of pathogen resistance to antibiotics requires the development of no
109                                    Genes for resistance to antibiotics such as acriflavin, bacitracin
110                             With the rise in resistance to antibiotics such as methicillin, there is
111 NA) modulates ribosomal function and confers resistance to antibiotics targeted to the ribosome.
112 in mixed cultures was associated with higher resistance to antibiotics than in either monoculture.
113 ncluding cell wall remodeling (and therefore resistance to antibiotics that target bacterial cell wal
114 lly characterized VgaA, LsaA and MsrE confer resistance to antibiotics that target the peptidyl trans
115 aminoglycoside O-phosphotransferases, confer resistance to antibiotics that were not administered in
116         The emergence of bacterial multidrug resistance to antibiotics threatens to cause regression
117 omised by the ability of bacteria to develop resistance to antibiotics through mutations or through t
118                                 Due to their resistance to antibiotics, treatment is often very chall
119 inistered drug, as well as genes that confer resistance to antibiotics unrelated to the administered
120 across multiple high-mortality settings, and resistance to antibiotics used for sepsis treatment was
121       Strains with rRNA mutations conferring resistance to antibiotics used in acne treatment were do
122                                    Bacterial resistance to antibiotics usually incurs a fitness cost
123                  Bacteria can rapidly evolve resistance to antibiotics via the SOS response, a state
124  No genomic microevolution and no Legionella resistance to antibiotics were detected.
125 estimating the degree of E. coli JM109 cells resistance to antibiotics within 2-5h using disposable s
126                                   Increasing resistance to antibiotics worldwide has adverse effects

 
Page Top